CATX — Perspective Therapeutics Balance Sheet
0.000.00%
- $189.57m
- -$35.67m
- $1.45m
Annual balance sheet for Perspective Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.39 | 63.8 | 55.9 | 9.24 | 227 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.08 | 2.04 | 1.63 | 1.18 | 1.48 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.51 | 67.3 | 59.3 | 16.8 | 231 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.74 | 2.73 | 2.49 | 6.32 | 59.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 8.7 | 70.4 | 64.4 | 97.9 | 341 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.57 | 1.8 | 2.27 | 15.7 | 18.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.98 | 3.01 | 3.16 | 22.7 | 50.4 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.72 | 67.4 | 61.3 | 75.2 | 291 |
Total Liabilities & Shareholders' Equity | 8.7 | 70.4 | 64.4 | 97.9 | 341 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |